HRSA Announces Action to Lower Out-of-Pocket Costs for Life-Saving Medications at Health Centers Nationwide

U.S. Department of Health and Human Services
Health Resources and Services Administration For Immediate Release

June 24, 2025

HRSA News Room newsroom.hrsa.gov Contact: HRSA PRESS OFFICE Phone: 301-443-7070 Media Inquiries: Submit via this form New Requirements Ensure Health Centers Provide Insulin and Injectable Epinephrine at Lower Costs to Patients

The Health Resources and Services Administration (HRSA) today announced new steps to lower out-of-pocket costs for life-saving medications. In alignment with President Trump’s Executive Order “ Lowering Drug Prices by Putting Americans First,” HRSA has issued updated award terms requiring HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program.

“Every American should be able to afford the prescription medications they rely on to live a healthy life,” said HRSA Administrator Tom Engels. “Today’s action ensures that HRSA-funded health centers pass these critical cost savings on to patients, helping millions maintain access to essential treatments. It reflects the Administration’s continued commitment to lower drug prices and Make America Healthy Again.”

This new requirement aims to improve access and affordability for two of the most vital medications in emergency and chronic care: insulin, used by millions of Americans to manage diabetes, and injectable epinephrine, critical for the treatment of severe allergic reactions. The high costs of these medications have posed a growing challenge for underserved populations.

HRSA-funded health centers deliver comprehensive primary care—regardless of an individual’s ability to pay—to over 31 million patients through more than 15,500 service sites nationwide. Notably, more than 90% of health center patients have incomes below 200% of the Federal Poverty Level.

The 340B Drug Pricing Program allows eligible health care organizations to purchase outpatient drugs at significantly reduced prices. The savings generated help expand services, support outreach, and improve health outcomes in underserved communities.

Health centers are encouraged to begin implementing these updated award terms immediately to ensure full compliance and maximize patient benefit.

To locate a nearby health center, visit Find a Health Center.

Date Last Reviewed:

June 2025

Back to Listing

Get HRSA Press Releases In Your Inbox

NOTE: You will only get HRSA press releases through our email list. To receive HHS press releases about HRSA, sign up with HHS.